- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266043
Early Treatment Outcomes in Pierre-Robin-Like Phenotype
Cohort Study on Prevalence and Early Treatment Outcomes in Pierre-Robin-Like Phenotype
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pierre-Robin sequence consists of a small lower jaw, a retropositioned tongue (glossoptosis), and optionally cleft palate, leading to severe upper airway obstruction and failure to thrive; occasionally even to sudden infant death. Treatment approaches are heterogeneous, some are considerably invasive; few have been evaluated by objective tests.
In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate on upper airway obstruction and failure to thrive using objective criteria (mixed-obstructive apnea index assessed by polysomnography, standard deviation score for body weight) upon admission and 3 months after hospital discharge. The pre-epiglottic baton plate is the main treatment approach currently used in Germany for this condition and practised standard care in the three participating study centers.
These data will help to compare the effect of the main treatment currently used in Germany with international data on more invasive treatments used in this rare condition.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Cologne, Germany, 50924
- Centre of Competence for Oro- and Craniofacial Malformations and Department of Neonatology, Univ. Hospital of Cologne
-
Tuebingen, Germany, 72076
- Dept. of Neonatology and Interdisciplinary Centre for Craniofacial Malformations, University Hospital Tuebingen
-
Würzburg, Germany, 97080
- Dept. of Orthodontics and University Children's Hospital, University Hospital of Wuerzburg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infants < 1 year at admission, Pierre-Robin-like phenotype
Exclusion Criteria:
- no parental consent; need for immediate tracheotomy
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mixed-obstructive apnea index (MOAI)
Time Frame: upon admission within the first year of life (before start of treatment) and 3 months after hospital discharge
|
Change in mixed-obstructive apnea index (MOAI) assessed by polygraphy from pre- to post-intervention as a marker of Pierre-Robin-sequence-related breathing disorder
|
upon admission within the first year of life (before start of treatment) and 3 months after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in standard deviation score for body weight
Time Frame: upon admission within the first year of life (before start of treatment) and 3 months after hospital discharge
|
Body weight will be obtained by electronic scales and the standard deviation score for weight calculated
|
upon admission within the first year of life (before start of treatment) and 3 months after hospital discharge
|
|
Duration of hospital stay
Time Frame: admission within the first year of life for initiation of study intervention
|
admission within the first year of life for initiation of study intervention
|
|
|
Treatment failure
Time Frame: 3 months after admission for initiation of study intervention
|
3 months after admission for initiation of study intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christian F Poets, MD, Dept. of Neonatology and Interdisciplinary Centre forCraniofacial Malformations, University Hospital Tuebingen
- Principal Investigator: Siegmar Reinert, MD, PhD, Dept. of Craniofacial Surgery, University Hospital Tuebingen
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FACE-Subproject SP5-Tuebingen
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.